PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
We present results from depth-resolved light scattering measurements of triple transgenic mouse retinas for Alzheimer’s Disease (AD) using a multimodal coherent imaging system. Use of a co-registered angle-resolved low-coherence interferometry (a/LCI) and optical coherence tomography (OCT) system allows unique analysis that is otherwise unavailable using a single modality to provide complementary information on tissue structural changes associated with AD. This abstract summarizes the light scattering parameters drawn using this system at selective retinal layers guided by OCT image segmentation. Future developments of this combined system for human retinal imaging, which involve a low-cost OCT engine, are also discussed.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
The alert did not successfully save. Please try again later.
Ge Song, Zachary A. Steelman, Stella Finkelstein, Ziyun Yang, Ludovic Martin, Kengyeh K. Chu, Sina Farsiu, Vadim Y. Arshavsky, Adam Wax, "Light scattering measurements of retinal biomarkers of Alzheimer’s disease guided by low-cost optical coherence tomography," Proc. SPIE 11657, Biomedical Applications of Light Scattering XI, 116570E (5 March 2021); https://doi.org/10.1117/12.2576911